Institutional investors purchased a net $2.3 million shares of ILMN during the quarter ended September 2013 and now own 115.72% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.5 Million shares of Illumina Inc
DEUTSCHE BANK SECURITIES, INC. Bought 714.0 Thousand shares of Illumina Inc
D. E. SHAW & CO. LP Bought 548.1 Thousand shares of Illumina Inc